These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26897518)

  • 1. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
    Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
    BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
    BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
    Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
    Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
    Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
    BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
    Hendriks N; Koeneman MM; van de Sande AJM; Penders CGJ; Piek JMJ; Kooreman LFS; van Kuijk SMJ; Hoosemans L; Sep SJS; de Vos Van Steenwijk PJ; van Beekhuizen HJ; Slangen BFM; Nijman HW; Kruitwagen RFPM; Kruse AJ
    J Immunother; 2022 Apr; 45(3):180-186. PubMed ID: 35180719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
    Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
    Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
    Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
    Polterauer S; Reich O; Widschwendter A; Hadjari L; Bogner G; Reinthaller A; Joura E; Trutnovsky G; Ciresa-Koenig A; Ganhoer-Schimboeck J; Boehm I; Berger R; Langthaler E; Aberle SW; Heinze G; Gleiss A; Grimm C
    Gynecol Oncol; 2022 Apr; 165(1):23-29. PubMed ID: 35177279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
    de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
    Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
    Sheth SS; Oh JE; Bellone S; Siegel ER; Greenman M; Mutlu L; McNamara B; Pathy S; Clark M; Azodi M; Altwerger G; Andikyan V; Huang G; Ratner E; Kim DJ; Iwasaki A; Levi AW; Buza N; Hui P; Flaherty S; Schwartz PE; Santin AD
    Clin Cancer Res; 2024 May; 30(9):1768-1777. PubMed ID: 38592381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
    Chen FP
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):475-8. PubMed ID: 24411029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
    Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
    BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
    Geisler S; Speiser S; Speiser L; Heinze G; Rosenthal A; Speiser P
    Obstet Gynecol; 2016 Feb; 127(2):353-9. PubMed ID: 26942365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
    van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
    Diaz-Arrastia C; Arany I; Robazetti SC; Dinh TV; Gatalica Z; Tyring SK; Hannigan E
    Clin Cancer Res; 2001 Oct; 7(10):3031-3. PubMed ID: 11595691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
    Smith JS; Sanusi B; Swarts A; Faesen M; Levin S; Goeieman B; Ramotshela S; Rakhombe N; Williamson AL; Michelow P; Omar T; Hudgens MG; Firnhaber C
    Am J Obstet Gynecol; 2017 Aug; 217(2):183.e1-183.e11. PubMed ID: 28366730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Inayama Y; Takamatsu S; Hamanishi J; Mizuno K; Horinouchi N; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Kosaka K; Efthimiou O; Kawakami K; Furukawa TA; Mandai M
    Obstet Gynecol; 2023 Aug; 142(2):307-318. PubMed ID: 37411024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
    Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
    Pachman DR; Barton DL; Clayton AC; McGovern RM; Jefferies JA; Novotny PJ; Sloan JA; Loprinzi CL; Gostout BS
    Am J Obstet Gynecol; 2012 Jan; 206(1):42.e1-7. PubMed ID: 21907959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.